Publicaciones (37) Publicaciones de BELÉN RUBIO RUIZ

2024

  1. Hydroxytyrosyl punicate: A first overview of a novel phenolipid with antiproliferative and antitrypanosomal activity

    Journal of Functional Foods, Vol. 117

2023

  1. In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

    Nano Letters, Vol. 23, Núm. 3, pp. 804-811

  2. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

    European Journal of Medicinal Chemistry, Vol. 258

  3. New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer

    European Journal of Medicinal Chemistry, Vol. 248

2022

  1. A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry in Vitro and in Vivo

    Journal of Medicinal Chemistry, Vol. 65, Núm. 1, pp. 552-561

  2. Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles

    Pharmaceutics, Vol. 14, Núm. 4

2021

  1. A minimally-masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry

    Bioorganic and Medicinal Chemistry, Vol. 41

  2. Nondestructive production of exosomes loaded with ultrathin palladium nanosheets for targeted bio-orthogonal catalysis

    Nature Protocols, Vol. 16, Núm. 1, pp. 131-163

  3. Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition

    Medicinal Research Reviews, Vol. 41, Núm. 2, pp. 902-927

2020

  1. Bioorthogonal Uncaging of Cytotoxic Paclitaxel through Pd Nanosheet-Hydrogel Frameworks

    Journal of medicinal chemistry, Vol. 63, Núm. 17, pp. 9650-9659

2019

  1. Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis

    Nature Catalysis, Vol. 2, Núm. 10, pp. 864-872

  2. Design and manufacture of functional catalyst-carrier structures for the bioorthogonal activation of anticancer agents

    New Journal of Chemistry, Vol. 43, Núm. 3, pp. 1449-1458

  3. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents

    Future Medicinal Chemistry, Vol. 11, Núm. 2, pp. 83-95

2018

  1. Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices

    Chemistry - A European Journal, Vol. 24, Núm. 63, pp. 16783-16790

  2. Bright insights into palladium-triggered local chemotherapy

    Chemical Science, Vol. 9, Núm. 37, pp. 7354-7361

  3. High-Precision Photothermal Ablation Using Biocompatible Palladium Nanoparticles and Laser Scanning Microscopy

    ACS Applied Materials and Interfaces, Vol. 10, Núm. 4, pp. 3341-3348

  4. Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action

    Metallomics, Vol. 10, Núm. 1, pp. 93-107

2017

  1. Choline kinase inhibition and docking studies of a series of 6-(benzylthio)-9H-purin-9-yl-pyridinium derivatives

    Medicinal Chemistry Research, Vol. 26, Núm. 11, pp. 2809-2815

  2. Evolución de las tasas universitarias en Europa. El caso español

    Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XIV FECIES

  3. Gold-Triggered Uncaging Chemistry in Living Systems

    Angewandte Chemie - International Edition, Vol. 56, Núm. 41, pp. 12548-12552